TOOLS

Top Insiders Stocks

Notification Center

Penny Stock Screener

Technical Analysis Screener

Top Analyst Stocks

Top Smart Score Stocks

Top Insiders Stocks

Trending Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

Top Gainers/losers/active ETFs

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Top Online Brokers

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

STOCKS

Rezolute reports Q2 EPS (26c), consensus (32c)

TheFly

Anticipates initiation of global Phase 3 clinical study for RZ358 in mid 2023.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on RZLT:

Disclaimer & Disclosure Report an Issue

Latest News Feed

More Market News >

More Articles

Stock Comparison

Quantum Computing AI Cryptocurrency Bitcoin Stocks Dividend Value Biotech Oil Chinese Chat GPT Banks Airline Beer & Beverages Energy

Investment Ideas

Analyst Top Stocks Smart Score Stocks Stock Screener Top Wall Street Analysts Insiders' Hot Stocks Top Penny Stocks Unusual Options Activity Top ETFs by Upside Potential